Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hui TSK"'
Autor:
Chen F; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; Department of Clinical Oncology, Hong Kong University Li Ka Shing Medical School, Hong Kong, Hong Kong SAR, China., Jin JY; Department of Radiation Oncology, Case Western Reserve University, Cleveland, OH, United States., Hui TSK; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Jing H; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Zhang H; Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, United States., Nong Y; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Han Y; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Wang W; Department of Radiation Oncology, Case Western Reserve University, Cleveland, OH, United States., Ma L; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Yi F; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Chen Q; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Zhang Y; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Fu P; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, United States., Yang L; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Xu Z; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Kong FS; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; Department of Clinical Oncology, Hong Kong University Li Ka Shing Medical School, Hong Kong, Hong Kong SAR, China.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Apr 28; Vol. 12, pp. 768956. Date of Electronic Publication: 2022 Apr 28 (Print Publication: 2022).
Autor:
Chen F; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China., Hui TSK; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Ma L; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Nong Y; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Han Y; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Jing H; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Lee EKW; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Xu Z; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Fu P; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, United States., Chang ATY; Comprehensive Oncology Center, Hong Kong Sanatorium & Hospital, Hong Kong, Hong Kong SAR, China., Hsue V; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China., Kong FS; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Feb 03; Vol. 12, pp. 811794. Date of Electronic Publication: 2022 Feb 03 (Print Publication: 2022).